We take a look at some of the exciting diabetes research developments announced in October 2025, and what the findings could mean for people living with or affected by diabetes.

The drug manufacturer Novo Nordisk has announced it will withdraw Levemir insulin in all forms by the end of 2026. Here, we look at what this means for people with diabetes who are affected, and what ...

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...

Our new stigma research looks at diabetes stigma at scale across the UK. With blame, shame and stigma staggeringly high across type 1 diabetes and type 2 diabetes – what can be done to tackle it?

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

We take a look at some of the exciting diabetes research developments announced in July, and what the findings could mean for people living with or affected by diabetes. Type 2 prevention, gene ...

Our research has provided the most detailed picture yet of how weight loss improves health. The findings offer important clues about how losing weight can help people with type 2 diabetes improve ...

On Thursday 3 July the government published its 10 Year Health Plan, setting out its ambition to rebuild the NHS and bring care closer to home.

Lucy, our Head of Research Impact and Communications, shares the moment she was diagnosed with type 1 diabetes. And how research has revealed that her journey with type 1 began long before any ...

We take a look at some of the exciting diabetes research developments announced in May, and what the findings could mean for people living with or affected by diabetes.

The main treatment for type 1 diabetes is insulin - but carb counting, eating well, activity and diabetes tech can help you manage your blood sugar levels ...

Our new research shows that 97% of people from South Asian, Black African and Black Caribbean communities in the UK have experienced some kind of diabetes-related stigma.